Abingdon Health Plc

LSE ABDX.L

Abingdon Health Plc Share Price on February 03, 2025: USD 0.10

Abingdon Health Plc Share Price is USD 0.10 on February 03, 2025, a -13.23% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Abingdon Health Plc 52-week high Share Price is USD 0.15 on June 12, 2024, which is 47.91% above the current Share Price.
Abingdon Health Plc 52-week low Share Price is USD 0.09 on March 13, 2024, which is -13.19% below the current Share Price.
Abingdon Health Plc average Share Price for the last 52 weeks is USD 0.12.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

LSE: ABDX.L

Abingdon Health Plc

CEO	Mr. Chris Henry Francis Yates
IPO Date	Dec. 15, 2020
Location	United Kingdom
Headquarters	York Biotech Campus
Employees	84
Sector	Technology
Industries 3D Printing Biotechnology Hardware & Electronics Medical Instruments Mobile Apps Pharmaceuticals Smartphones Telehealth

Description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Key trends

Past 5 years